FMC CORP(FMC)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,436 of 2,879 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
FMC Stock Analysis & AI Quality Score
AI stock analysis and institutional research for FMC CORP (FMC), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores FMC at 28.6/100 on a 32-signal composite quality model, placing it at rank #2,436 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (11.1) and free cash flow (15.0), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q4 2025), FMC CORP reports quarterly revenue of $1.1B, net income of $-1.7B, free cash flow of $631.1M. Top institutional holders of FMC by reported 13-F value include BlackRock,, AQR CAPITAL MANAGEMENT, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. FMC trades on the NYSE exchange and files with the SEC under CIK 37785. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate FMC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for FMC CORP directly from SEC EDGAR. FMC CORP's 13F Pro composite quality score has ranged between 8 and 65 since 2021, currently 28.6 — a declining long-term trajectory across 56 quarterly and live scoring snapshots.
Revenue
Q4 2025
$1.1B
Net Income
Q4 2025
$-1.7B
Free Cash Flow
Q4 2025
$631.1M
ROIC
Q4 2025
-26.1%
D/E Ratio
Q4 2025
1.97
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
-18.3% YoYNet Income
-756.4% YoYOperating Income
-421.5% YoYEPS (Diluted)
-757.4% YoYTotal Assets
-16.9% YoYTotal Debt
+21.1% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $3.47B -18.3% | $4.25B -5.4% | $4.49B -22.7% | $5.80B +15.0% | $5.05B +8.7% | $4.64B |
| Net Income | $-2.24B -756.4% | $341.1M -74.2% | $1.32B +79.4% | $736.5M -0.4% | $739.6M +33.9% | $552.4M |
| Operating Income | $-1.63B -421.5% | $506.5M -8.8% | $555.6M -51.4% | $1.14B +10.6% | $1.03B +15.3% | $896.9M |
| EPS (Diluted) | $-17.88 -757.4% | $2.72 -74.2% | $10.53 +81.2% | $5.81 +1.4% | $5.73 +35.5% | $4.23 |
| Total Assets | $9.69B -16.9% | $11.65B -2.3% | $11.93B +6.8% | $11.17B +4.7% | $10.67B +4.8% | $10.19B |
| Total Debt | $4.07B +21.1% | $3.37B -15.0% | $3.96B +20.9% | $3.27B +3.2% | $3.17B -2.9% | $3.27B |
Get alerted when FMC's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for FMC CORP including:
Top Institutional Holders of FMC
BlackRock, Inc.
$322.0M18,696,604 shAQR CAPITAL MANAGEMENT LLC
$158.2M9,261,783 shVANGUARD PORTFOLIO MANAGEMENT LLC
$132.5M7,696,658 shD. E. Shaw & Co., Inc.
$103.6M6,016,027 shVANGUARD CAPITAL MANAGEMENT LLC
$99.3M5,766,364 shSTATE STREET CORP
$83.0M4,800,031 shMORGAN STANLEY
$58.5M3,399,801 shTWO SIGMA INVESTMENTS, LP
$41.0M2,381,816 shAMERICAN CENTURY COMPANIES INC
$36.4M2,113,837 shGEODE CAPITAL MANAGEMENT, LLC
$36.2M2,101,346 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $322.0M | 18,696,604 |
| AQR CAPITAL MANAGEMENT LLC | $158.2M | 9,261,783 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $132.5M | 7,696,658 |
| D. E. Shaw & Co., Inc. | $103.6M | 6,016,027 |
| VANGUARD CAPITAL MANAGEMENT LLC | $99.3M | 5,766,364 |
| STATE STREET CORP | $83.0M | 4,800,031 |
| MORGAN STANLEY | $58.5M | 3,399,801 |
| TWO SIGMA INVESTMENTS, LP | $41.0M | 2,381,816 |
| AMERICAN CENTURY COMPANIES INC | $36.4M | 2,113,837 |
| GEODE CAPITAL MANAGEMENT, LLC | $36.2M | 2,101,346 |
More Healthcare Companies
View all Healthcare →Put FMC on your watchlist
Track score changes the day FMC CORP files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is FMC a good stock to buy?
13F Pro's AI-powered analysis of FMC CORP (FMC) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for FMC are available on the FMC stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own FMC?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling FMC. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of FMC CORP's investment landscape.